At the AD/PD 2025 Conference yesterday, Annovis Bio presented their latest findings showing buntanetap’s ability to improve cognitive and motor functions in early PD patients. Good news: After much searching, I found a video of their presentation. Less good news: There seemed to be nothing new in it. But if you'd like to see for yourself, follow these steps:
Visit portal.unlok-education.com/...
Click on [Click Here]
Search for “Maccecchini” (without the quotes)
Click [Play]
Skip ahead to 1:32:50
#buntanetap
Annovis Bio have published the results of their dose-finding, biomarker study of buntanetap in 14 early Alzheimers & 14 Parkinsons patients
Annovis Bio Announces First Patient Dosed in Phase 3 Trial in Patients with Early Parkinson’s Disease
